PET三明治:系列FDG-PET联合间期爆发抑制评估疾病的发作期成分
该文报告6例出现发作期或发作间期连续(IIC)脑电异常、严重神经损伤且临床怀疑存在混杂病理的重症患者,均接受持续视频脑电监测。5例接受至少两次系列FDG-PET(基线和脑电爆发抑制状态下),1例仅在爆发抑制状态下接受单次FDG-PET。4例患者基线FDG高代谢灶在爆发抑制后消失,升级抗癫痫治疗获临床改善,提示原发性发作期病理;2例患者高代谢灶在爆发抑制后持续存在,分别经尸检确诊单纯疱疹病毒脑炎和临床诊断为检查点抑制剂诱导的自身免疫性脑炎,后者通过升级免疫抑制治疗获得成功。作者认为,在适当选择患者中,爆发抑制状态下的FDG-PET可能有助于区分IIC的病理生理原因并指导个体化治疗。
要点
- 对重症患者出现发作期或IIC脑电异常且怀疑混杂病理时,可在爆发抑制状态下行FDG-PET,若高代谢灶消失提示原发性发作期病理,升级抗癫痫治疗可能有效。
- 若爆发抑制后FDG高代谢灶持续存在,提示非发作期病理(如感染或自身免疫性),需针对病因治疗而非单纯升级抗癫痫药物。
- 6例患者中4例高代谢灶随爆发抑制消失并临床改善,2例高代谢灶持续存在,分别确诊为单纯疱疹病毒脑炎和检查点抑制剂诱导的自身免疫性脑炎。
- 所有患者均接受持续视频脑电监测,5例接受至少两次FDG-PET(基线和爆发抑制状态),1例仅行爆发抑制状态下单次FDG-PET。
- 作者提出,系列FDG-PET联合诱导脑电爆发抑制或可帮助鉴别原发性与继发性发作期病理,指导靶向治疗。
适用人群与场景
- 出现发作期或发作间期连续(IIC)脑电异常、严重神经损伤且临床怀疑存在混杂病理的重症患者。
处置流程与药物剂量
- 所有患者均接受持续视频脑电监测(cvEEG)。
- 5例患者接受至少两次系列FDG-PET脑扫描:一次在基线状态,第二次在脑电爆发抑制状态下;1例患者仅在爆发抑制状态下接受单次FDG-PET扫描。
- 比较爆发抑制前后的FDG高代谢灶和脑电描记。
- 对FDG高代谢灶随爆发抑制消失的患者,升级抗癫痫治疗;对高代谢灶持续存在的患者,针对非发作期病理进行治疗(如免疫抑制治疗)。
研究设计与关键结果
- 研究类型为病例系列,报告6例患者。4例患者基线FDG高代谢灶在爆发抑制后消失,升级抗癫痫治疗获临床改善,临床诊断分别为电临床癫痫持续状态、新发难治性癫痫持续状态、放疗后卒中样偏头痛发作和炎症性脑淀粉样血管病继发癫痫。
- 2例患者脑电高度异常且FDG高代谢灶在爆发抑制后持续存在:第1例表现为查体差、发热、怀疑脑炎,尸检病理证实单纯疱疹病毒脑炎;第2例怀疑检查点抑制剂诱导的自身免疫性脑炎,高代谢灶持续存在指导成功升级免疫抑制治疗。
证据类型、等级与局限
- 证据类型:病例系列(6例)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在适当选择的重症患者中,爆发抑制状态下的FDG-PET可能有助于剖析脑电IIC表现的潜在病理生理原因并指导个体化治疗。
- 作者提出,麻醉药物抑制高代谢灶提示对升级抗癫痫治疗有临床反应性,而不可抑制的高代谢灶提示非发作期病理,可能需要多模式治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Determining the cause of refractory seizures and/or interictal continuum (IIC) findings in the critically ill patient remains a challenge. These electrographic abnormalities may represent primary ictal pathology or may instead be driven by an underlying infectious, inflammatory, or neoplastic pathology that requires targeted therapy. In these cases, it is unclear whether escalating antiepileptic therapy will be helpful or harmful. Herein, we report the use of serial [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) coupled with induced electrographic burst suppression to distinguish between primary and secondary ictal pathologies. We propose that anesthetic suppression of hypermetabolic foci suggests clinical responsiveness to escalating antiepileptic therapy, whereas non-suppressible hypermetabolic foci are suggestive of non-ictal pathologies that likely require multimodal therapy.
METHODS: We describe 6 patients who presented with electrographic findings of seizure or IIC abnormalities, severe neurologic injury, and clinical concern for confounding pathologies. All patients were continuously monitored on video electroencephalography (cvEEG). Five patients underwent at least two sequential FDG-PET scans of the brain: one in a baseline state and the second while under electrographic burst suppression. FDG-avid loci and EEG tracings were compared pre- and post-burst suppression. One patient underwent a single FDG-PET scan while burst-suppressed.
RESULTS: Four patients had initially FDG-avid foci that subsequently resolved with burst suppression. Escalation of antiepileptic therapy in these patients resulted in clinical improvement, suggesting that the foci were related to primary ictal pathology. These included clinical diagnoses of electroclinical status epilepticus, new-onset refractory status epilepticus, stroke-like migraine attacks after radiotherapy, and epilepsy secondary to inflammatory cerebral amyloid angiopathy. Conversely, two patients with high-grade EEG abnormalities had FDG-avid foci that persisted despite burst suppression. The first presented with a poor examination, fever, and concern for encephalitis. Postmortem pathology confirmed suspicion of herpes simplex virus encephalitis. The second patient presented with concern for checkpoint inhibitor-induced autoimmune encephalitis. The persistence of the FDG-avid focus, despite electrographic burst suppression, guided successful treatment through escalation of immunosuppressive therapy.
CONCLUSIONS: In appropriately selected patients, FDG-PET scans while in burst suppression may help dissect the underlying pathophysiologic cause of IIC findings observed on EEG and guide tailored therapy.
参考来源
- Akbik F, Robertson M, Das AS, et al. The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease. Neurocrit Care. 2020. PMID: 32253731. doi:10.1007/s12028-020-00956-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。